Influenza Patents (Class 514/888)
  • Repairing agent for cells and tissues
    Patent number: 5015631
    Abstract: A repairing agent for cells and tissues is disclosed, which agent comprises, as an active ingredient, a compound of the general formula: ##STR1## wherein Z represents lithium, potassium, sodium, ammonium or an organic ammonium when n is 1, and Z represents calcium, barium or magnesium when n is 2.
    Type: Grant
    Filed: June 24, 1988
    Date of Patent: May 14, 1991
    Assignee: MECT Corporation
    Inventors: Sadanori Ogasawara, Kenji Abiko, Masayoshi Ito, Yoshiyasu Shitori
  • Flavor masked ionizable zinc compositions for oral absorption
    Patent number: 5002970
    Abstract: An oral composition containing ionizable compounds of zinc flavor-masked with anethole and prepared in the forms of pleasant tasting lozenges, soft candies, syrups, powders and chewing gums for delivery of zinc to the oral and oral pharyngeal mucosa of a human with said composition being absent the taste or aftertaste of zinc, and being primarily intended for use in treating the common cold.
    Type: Grant
    Filed: April 18, 1988
    Date of Patent: March 26, 1991
    Inventor: George A. Eby, III
  • 16-substituted androstanes and 16-substituted androstenes
    Patent number: 5001119
    Abstract: Compounds of the formula: ##STR1## are useful as anti-cancer, anti-obesity, anti-diabetic, anti-coronary agents, anti-aging agents, anti-hypolipidemic agents and anti-autoimmune agents.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: March 19, 1991
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • Method for reducing the duration of the common cold
    Patent number: 4956385
    Abstract: This invention discloses and claims improved methods to reduce duration of common colds in humans through use of pharmaceutically acceptable zinc compounds topically and frequently applied to the oral mucosa by various means. The invention improves upon the prior art using zinc gluconate throat lozenges to reduce the duration of common colds and zinc borate intranasally as an astringent and decongestant in treatment of common colds.
    Type: Grant
    Filed: September 24, 1987
    Date of Patent: September 11, 1990
    Inventor: George A. Eby, III
  • Detergent compositions
    Patent number: 4948576
    Abstract: This invention relates to detergent compositions comprising at least one surfactant, at least one water-soluble nitrogen-containing polymer and a water-soluble, non-particulate substance capable of imparting a desired residual effect to a specific substrate such as the scalp or skin.
    Type: Grant
    Filed: February 18, 1983
    Date of Patent: August 14, 1990
    Assignee: Johnson & Johnson Consumer Products, Inc.
    Inventors: Robert J. Verdicchio, Diane L. Spilatro
  • Antiviral agent
    Patent number: 4784853
    Abstract: An antiviral agent containing as its active ingredient, an ingredient extracted from Crocosmia x crocosmaeflora N.E. Br.
    Type: Grant
    Filed: May 4, 1987
    Date of Patent: November 15, 1988
    Assignee: Chisso Corporation
    Inventors: Takeshi Inoi, Hiroaki Ishibashi, Etsuro Yoshikawa
  • Methods and compositions for inhibiting the infectious activity of viruses
    Patent number: 4742046
    Abstract: Diseases of animals and man caused by enveloped viruses can be inhibited by the use of non-toxic lectins. Suitable compositions and methods of administration of such lectins are described.
    Type: Grant
    Filed: June 27, 1985
    Date of Patent: May 3, 1988
    Assignee: Medisearch S.A.
    Inventor: Madeleine A. M. Bliah
  • Method for reducing the duration of the common cold
    Patent number: RE33465
    Abstract: The invention disclosed and claimed is a method to reduce duration of common colds in humans as evinced by reduction of duration of 10 common cold symptoms through use of zinc gluconate topically and frequently applied to the oral mucosa. The invention improves upon the prior art using zinc intranasally as an astringent and decongestant in treatment of common colds. Results of a clinical study are presented in support of disclosure and claims.
    Type: Grant
    Filed: April 4, 1986
    Date of Patent: November 27, 1990
    Inventor: George A. Eby, III